Search research articles
Contact Us
Filters
Showing results (91-100 of 97) with videos related to
Page
of 10
Sort By:
You have reached the last page of results.
This site can display upto 97 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas
Monica Fedele, Ivana De Martino, Rosario Pivonello, et al.
Oncotarget
|
August 6, 2016
PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas
Renato Franco, Giosuè Scognamiglio, Elena Valentino, et al.
International Journal of Cancer
|
January 25, 2002
Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement
Fulvio Basolo, Riccardo Giannini, Antonio Toniolo, et al.
Cancer Research
|
March 3, 2006
Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice
Monica Fedele, Vincenzo Fidanza, Sabrina Battista, et al.
Ebiomedicine
|
April 15, 2025
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance
Maria Mirabelli, Eusebio Chiefari, Biagio Arcidiacono, et al.
The Journal of Biological Chemistry
|
April 12, 2012
POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation
Raffaela Pero, Dario Palmieri, Tiziana Angrisano, et al.
Cellular and Molecular Life Sciences : CMLS
|
July 25, 2025
Fibroblasts activated by miRs-185-5p, miR-652-5p, and miR-1246 shape the tumor microenvironment in triple-negative breast cancer via PATZ1 downregulation
Giada De Luca, Gianluca Petrillo, Iolanda Scognamiglio, et al.
Page
of 10
Search research articles
Search
Showing results (91-100 of 97) with videos related to
Sort By:
Page
of 10
You have reached the last page of results.
This site can display upto 97 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2007
SOM230, a new somatostatin analogue, is highly effective in the therapy of growth hormone/prolactin-secreting pituitary adenomas
Monica Fedele, Ivana De Martino, Rosario Pivonello, et al.
Oncotarget
|
August 6, 2016
PATZ1 expression correlates positively with BAX and negatively with BCL6 and survival in human diffuse large B cell lymphomas
Renato Franco, Giosuè Scognamiglio, Elena Valentino, et al.
International Journal of Cancer
|
January 25, 2002
Establishment of a non-tumorigenic papillary thyroid cell line (FB-2) carrying the RET/PTC1 rearrangement
Fulvio Basolo, Riccardo Giannini, Antonio Toniolo, et al.
Cancer Research
|
March 3, 2006
Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice
Monica Fedele, Vincenzo Fidanza, Sabrina Battista, et al.
Ebiomedicine
|
April 15, 2025
HMGA1 deficiency: a pathogenic link between tau pathology and insulin resistance
Maria Mirabelli, Eusebio Chiefari, Biagio Arcidiacono, et al.
The Journal of Biological Chemistry
|
April 12, 2012
POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation
Raffaela Pero, Dario Palmieri, Tiziana Angrisano, et al.
Cellular and Molecular Life Sciences : CMLS
|
July 25, 2025
Fibroblasts activated by miRs-185-5p, miR-652-5p, and miR-1246 shape the tumor microenvironment in triple-negative breast cancer via PATZ1 downregulation
Giada De Luca, Gianluca Petrillo, Iolanda Scognamiglio, et al.
Page
of 10